$Sunstone Hotel Investors(SHO.US)$营收在2020年大幅萎缩76%,之后两年快速恢复,2022年达到2019年的82%,营业利润在2020和2021年亏损两年,2022年扭亏达到2019年的61%,净利润也类似,2022年达到2019年的63%。 2023前两季度营收增长22.7%,营业利润增长99.3%,受利息费用大幅增加和资产出售收益减少影响,净利润仅增长21.5%。 目前市盈率26.6,市盈率TTM下降到21.5,如果不计算疫情的两年,另外3年平均净利润为1.6亿,对应市盈率为11.7,股息率2.2%,市净率1.03,综合来看吸引力不大。
Gainers: In reaction to earnings/guidance: •$Silvergate Capital(SI.US)$+10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.) •$AxoGen(AXGN.US)$+3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization), •$诺华制药(NVS.US)$+ 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
Sunstone Hotel Investors股票讨论区
2023前两季度营收增长22.7%,营业利润增长99.3%,受利息费用大幅增加和资产出售收益减少影响,净利润仅增长21.5%。
目前市盈率26.6,市盈率TTM下降到21.5,如果不计算疫情的两年,另外3年平均净利润为1.6亿,对应市盈率为11.7,股息率2.2%,市净率1.03,综合来看吸引力不大。
专栏Today's pre-market stock movers: NFLX, IBM, LMT, SI and more
In reaction to earnings/guidance:
• $Silvergate Capital(SI.US)$ +10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.)
• $AxoGen(AXGN.US)$ +3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization),
• $诺华制药(NVS.US)$ + 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
looks good, on track with reopenings
暂无评论